Upgrade to SI Premium - Free Trial

Seattle Genetics (SGEN) Commences Tender Offer for Cascadian Therapeutics (CASC)

February 8, 2018 5:43 PM
Seattle Genetics, Inc. (NASDAQ: SGEN) today announced that its wholly-owned subsidiary, Valley Acquisition Sub, Inc., has commenced its previously announced ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Mergers and Acquisitions

Next Articles